Lazard Asset Management
MYOV

Lazard Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Lazard Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,643
Closed -$101K – 2616
2022
Q3 		$101K Hold
5,643
– – ﹤0.01% 1475
2022
Q2 		$70K Buy
+5,643
New +$62.3K ﹤0.01% 1663
2022
Q1 		– Sell
-3,803
Closed -$59K – 2599
2021
Q4 		$59K Buy
3,803
+3,230
+564% +$61.7K ﹤0.01% 1665
2021
Q3 		$12K Sell
573
-1,888
-77% -$41.5K ﹤0.01% 2066
2021
Q2 		$56K Buy
+2,461
New +$51.8K ﹤0.01% 1554
2020
Q4 		– Sell
-352
Closed -$4K – 2029
2020
Q3 		$4K Buy
+352
New +$6.55K ﹤0.01% 1556
2019
Q1 		– Sell
-25,443
Closed -$417K – 1216
2018
Q4 		$417K Hold
25,443
– – ﹤0.01% 810
2018
Q3 		$675K Buy
25,443
+10,954
+76% +$248K ﹤0.01% 795
2018
Q2 		$331K Buy
+14,489
New +$316K ﹤0.01% 806

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lazard Asset Management's MYOV Position: Q4 2022 in Review

Lazard Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 5,643 shares — an estimated $101K sold.

Lazard Asset Management first reported a position in MYOV in Q2 2018 and held it in 9 quarters. The position peaked at $675K in Q3 2018. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Lazard Asset Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Lazard Asset Management sold 5,643 Myovant Sciences Ltd. shares in Q4 2022, an estimated $101K.
  • Lazard Asset Management first reported a position in Myovant Sciences Ltd. in Q2 2018 and held it in 9 quarters.
  • Lazard Asset Management's Myovant Sciences Ltd. position peaked at $675K in Q3 2018.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.